Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial

McMurray, J. et al. (2009) Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial. European Journal of Heart Failure, 11(8), pp. 795-801.

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Young, Dr John and Young, Ms Janet and McMurray, Professor John
Authors: McMurray, J., Anand, I., Diaz, R., Maggioni, A., O'Connor, C., Pfeffer, M., Polu, K., Solomon, S., Sun, Y., Swedberg, K., Tendera, M., van Veldhuisen, D., Wasserman, S., Young, J., and Young, J.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
College of Medical Veterinary and Life Sciences
Journal Name:European Journal of Heart Failure

University Staff: Request a correction | Enlighten Editors: Update this record